Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of MK-0736 and MK-0916 in Hypertension
NCT00274716Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0736, MK-0916 in hypertension (HTN), sponsored by Merck & Co.. Started Nov 2005; status: completed.
02
Drugs
MK-0736MK-0916
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00274716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274716.